Compliance with tricyclic antidepressants: the value of four different methods of assessment

Abstract

Aims To assess the advantages and disadvantages of four methods for studying compliance with antidepressants: self-report scores, tablet counts, a microprocessor (MEMS) container system and the assay of nordothiepin and dothiepin concentrations in plasma. Methods The techniques were used in 88 patients commencing tricyclic antidepressants in the setting of UK general practice. Results The MEMS system proved to be the most informative technique allowing identi®cation of the precise time of container opening, the demonstration of`drug holidays' and early cessation of therapy. Self-report scores (Morisky) proved a useful screening technique with a sensitivity of 72.2% and speci®city of 74.1% for i80% compliance. Although tablet counts were possible in 84 patients (95.5%) they were unreliable in 19 (21.6%). Blood concentration assays proved the least acceptable method to patients and were possible in only 53 (60.2%). A ratio of nordothiepin:dothiepin i 1.1 claimed, by others, to identify noncompliance was only reliable when concentrations were low. Conclusions Both the MEMS system and self-report scores proved useful methods for identifying noncompliant patients in the setting of UK general practice. Although compliance was higher than reported in previous studies with 70 patients (79.5%) completing 6 weeks treatment, general practitioners tended to prescribe subtherapeutic doses.

Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs

“…This is because a substantial proportion of these patients had decided not to take the drug and of those who had taken it, a further proportion had not achieved a therapeutic dose, probably because the patients' general practitioner (George et al, 2000) did not increase doses. Even if a therapeutic dose was prescribed, a number either did not take it or had stopped taking it after only a short period.…”

Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial

“…A score of '0' (range 0-4) on this scale was indicative of at least 80% adherence. 49 Given the relatively long half-life of antidepressant medication, an additional item ('Did you miss 2 days' antidepressant tablets in a row?' yes/no) was added to this scale to ensure that only individuals who had missed more than one consecutive dose were excluded.…”

Prevalence of treatment-resistant depression in primary care: cross-sectional data

“…The questionnaire also asked about current antidepressant medication, including duration of treatment and adherence to antidepressants. The latter was assessed using the Morisky scale, 15,16 with an additional item added to ensure that individuals who had missed fewer than two consecutive doses were not excluded.…”